(Q24235153)

English

Tiotropium versus placebo for chronic obstructive pulmonary disease

scientific article (publication date: 10 August 2011)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Tiotropium versus placebo for chronic obstructive pulmonary disease (English)

0 references

main subject

placebo

0 references

chronic obstructive pulmonary disease

0 references

author

Phillippa Poole

series ordinal

3

0 references

author name string

Charlotta Karner

series ordinal

1

0 references

Jimmy Chong

series ordinal

2

0 references

publication date

10 August 2011

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

Tiotropium for stable chronic obstructive pulmonary disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009285

retrieved

21 January 2018

The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009285

retrieved

21 January 2018

Self-management education for patients with chronic obstructive pulmonary disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009285

retrieved

21 January 2018

Acute care costs of patients admitted for management of chronic obstructive pulmonary disease exacerbations: contribution of disease severity, infection and chronic heart failure

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009285

retrieved

21 January 2018

Pulmonary rehabilitation for chronic obstructive pulmonary disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009285

retrieved

21 January 2018

Cost effectiveness of tiotropium for chronic obstructive pulmonary disease: a systematic review of the evidence

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009285

retrieved

21 January 2018

Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditions

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009285

retrieved

21 January 2018

Beta2-agonist and anticholinergic drugs in the treatment of lung disease.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009285

retrieved

21 January 2018

Review: inhaled anticholinergics increase risk of major cardiovascular events in COPD.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009285

retrieved

21 January 2018

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009285

retrieved

21 January 2018

Smoking cessation for chronic obstructive pulmonary disease.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009285

retrieved

21 January 2018

Identifiers

DOI

10.1002/14651858.CD009285

0 references

(Q24235153)

Tiotropium versus placebo for chronic obstructive pulmonary disease

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)